News – Page 356 – Endpoints News

Analysts expect quiet first quarter as Big Pharma earnings begin to roll in

3 years ago

PharmaEssentia secures $462M+ to further growth of Besremi and its pipeline

3 years ago

Ocuphire CEO says her post was terminated with no cause given

3 years ago

Activist investor pushes Bayer to separate crop science, consumer health from pharma

3 years ago

FDA pushes back PDUFA date for Daiichi's AML drug quizartinib over REMS updates

3 years ago

Chinese biotech startup adds $315M to the bank after bringing 5 Takeda drugs to its fold

3 years ago

Junshi Biosciences touts lung cancer data as it looks to expand PD-1 label in China again

3 years ago

Amylyx welcomes former Alnylam exec to help expand Relyvrio; Amarin plugs in an interim chief

3 years ago

Federal appeals court bars generics for Otezla until 2028

3 years ago

Bausch Health’s Salix spotlights liver disease indication for Xifaxan

3 years ago

Bipartisan PBM reforms take root in Senate Finance Committee

3 years ago

Outgoing regulatory chief details hiring and retention challenges for FDA inspectors

3 years ago

Manufacturing roundup: Ajinomoto gets FDA approval for manufacturing line; PCI Pharma fill machines come online

3 years ago

KBI Biopharma and Selexis hire J.D. Mowery as new CEO

3 years ago

Astellas and Twist team up in antibodies; FDA asks DBV for an additional safety study in peanut allergy patch

3 years ago

Moderna, IBM turn to quantum computing in hunt for new mRNA medicines

3 years ago

BeiGene notches win for PD-1 drug in stomach cancers. When will partner Novartis submit for approval?

3 years ago

Haleon’s Excedrin brand advocates no-drug approach in ‘Head Care’ campaign with celebrity dancer

3 years ago

Updated: Indian CDMO opens 'dedicated' R&D site for Schrödinger as part of five-year agreement

3 years ago

FDA greenlights Roche's Polivy, expanding label into first-line DLBCL combo therapy

3 years ago

Biden's long-awaited NIH pick might be NCI chief Monica Bertagnolli — reports

3 years ago

Abdera raises $110M to push targeted radiotherapies where they haven’t gone before

3 years ago

Bristol Myers deepens ADC pipeline in $1B+ biobuck pact with Munich startup

3 years ago

AACR roundup: Merus eyes accelerated approval; Immuneering accelerates RAS drug

3 years ago

First page Previous page 353 354 355356357 358 359 Next page Last page